| |
| |
|
| Insider
Information: |
Rosenbaum David P. |
| Relationship: |
Chief Development Offi... |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
376,479 |
|
|
Indirect Shares
|
253,966 |
|
|
| Direct
Value |
$2,541,233 |
|
|
|
Indirect Value
|
$1,714,271 |
|
|
| Total
Shares |
630,445 |
|
|
| Total
Value |
$4,255,504 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
35
|
|
Stock
price went up :
|
1
|
23
|
| Stock
price went down : |
0
|
12
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.9
|
| Percentage
Gain/Loss : |
 276.6%
|
3,042.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardelyx Inc |
ARDX |
Chief Development Offi... |
2024-05-21 |
376,479 |
2024-05-21 |
253,966 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2017-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
17,985 |
40,129 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2017-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,512 |
66,641 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
I/I |
10,000 |
17,045 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2018-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
168,555 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
8,500 |
30,162 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
32,612 |
165,659 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
311,804 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-10-08 |
4 |
A |
$0.00 |
$0 |
I/I |
60,000 |
90,811 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
I/I |
15,000 |
105,627 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
351,161 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
I/I |
70,120 |
183,413 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
112,750 |
399,346 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-07-30 |
4 |
AS |
$19.27 |
$38,755 |
I/I |
(2,011) |
75,581 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-07-30 |
4/A |
AS |
$19.27 |
$38,755 |
D/D |
(2,011) |
25,880 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-01 |
4 |
AS |
$18.32 |
$23,560 |
I/I |
(1,286) |
0 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-03 |
4 |
AS |
$19.25 |
$24,082 |
D/D |
(1,251) |
25,880 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-15 |
4 |
AS |
$22.01 |
$55,898 |
I/I |
(2,540) |
75,052 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-15 |
4/A |
AS |
$22.01 |
$55,898 |
D/D |
(2,540) |
23,340 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-21 |
4 |
AS |
$22.09 |
$17,674 |
I/I |
(800) |
74,252 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-21 |
4/A |
AS |
$22.09 |
$17,674 |
D/D |
(800) |
22,540 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-22 |
4 |
AS |
$22.00 |
$13,200 |
D/D |
(600) |
73,652 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-22 |
4/A |
AS |
$22.00 |
$13,200 |
D/D |
(600) |
21,940 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2016-03-03 |
4 |
AS |
$10.74 |
$12,110 |
D/D |
(1,128) |
22,144 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-04-06 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
160,047 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• • – |
2023-09-08 |
4 |
AS |
$4.55 |
$13,181 |
D/D |
(2,897) |
367,022 |
0 |
% |
|
78 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
